Insulin-insulin-like growth factor axis and colon cancer

Journal of Clinical Oncology

Volumn 27, Issue 2, 2009, Pages 165-167

  Sridhar, Srikala S ^a   Goodwin, Pamela J ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; SOMATOMEDIN; IGFBP1 PROTEIN, HUMAN; IGFBP3 PROTEIN, HUMAN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C;

BODY MASS; CANCER RISK; COLON CANCER; COLON CARCINOGENESIS; EDITORIAL; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; BLOOD; COLON TUMOR; HUMAN; METABOLISM; NOTE;

COLONIC NEOPLASMS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; SOMATOMEDINS;

EID: 58249092148     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.19.8937     Document Type: Editorial

References (19)

1. McKeown-Eyssen G: Epidemiology of colorectal cancer revisited: Are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev 3:687-695, 1994
2. Goodwin PJ, Ennis M, Pritchard KI, et al: Fasting insulin and outcome in early-stage breast cancer: Results of a prospective cohort study. J Clin Oncol 20:42-51, 2002
3. Berrino F, Villarini A, De Petris M, et al: Adjuvant diet to improve hormonal and metabolic factors affecting breast cancer prognosis. Ann N Y Acad Sci 1089:110-118, 2006
4. Pollak M: Insulin-like growth factor-related signaling and cancer development. Recent Results Cancer Res 174:49-53, 2007
5. Goodwin PJ: Insulin in the adjuvant breast cancer setting: A novel therapeutic target for lifestyle and pharmacologic interventions? J Clin Oncol 26:833-834, 2008
6. Lahm H, Amstad P, Wyniger J, et al: Blockade of the insulin-like growth factor 1 receptor inhibits growth of human colorectal cancer cells: Evidence of a functional IGF-2-mediated autocrine loop. Int J Cancer 58:452-459, 1994
7. Giovannucci E, Pollak MN, Platz EA, et al: A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomarkers Prev 9:345-349, 2000
8. Ma J, Pollak MN, Giovannucci E, et al: Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 91:620-625, 1999
9. Sandhu MS, Dunger DB, Giovannucci EL: Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. J Natl Cancer Inst 94:972-980, 2002
10. Keku TO, Lund PK, Galanko J, et al: Insulin resistance, apoptosis, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 14:2076-2081, 2005
11. Bruce WR, Giacca A, Medline A: Possible mechanisms relating diet and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 9:1271-1279, 2000
12. Lasko CM, Bird RP: Modulation of aberrant crypt foci by dietary fat and caloric restriction: The effects of delayed intervention. Cancer Epidemiol Biomarkers Prev 4:49-55, 1995
13. Wolpin BM, Meyerhardt JA, Chan AT, et al: Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer. J Clin Oncol [epub ahead of print on December 8, 2008]
14. Meyerhardt JA, Niedzwiecki D, Hollis D, et al: Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: Findings from Cancer and Leukemia Group B 89803. J Clin Oncol 26:4109-4115, 2008
15. Dignam JJ, Polite BN, Yothers G, et al: Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J Natl Cancer Inst 98:1647-1654, 2006
16. Fred Hutchinson Cancer Research Center: Effect of exercise on biomarkers of colon cancer risk (APPEAL). http://clinicaltrials.gov/show/NCT00668161
17. Ontario Clinical Oncology Group, Novartis: Lifestyle intervention study in adjuvant treatment of early breast cancer (LISA). http://clinicaltrials.gov/ show/NCT00463489
18. National Library of Medicine. http://clinicaltrials.gov
19. Creighton CJ, Casa A, Lazard Z, et al: Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis. J Clin Oncol 26:4078-4085, 2008